Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Vi-DT Typhoid Conjugate Vaccine
BIOLOGICAL
2 trials
Sponsors
PT Bio Farma
Conditions
Immunogenicity
Safety Issues
Vaccine
Phase 2
Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian
Completed
NCT04741828
PT Bio Farma
Vaccine
Start: 2021-05-03
End: 2024-12-30
Updated: 2025-06-03
Phase 3
Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)
Completed
NCT04051268
PT Bio Farma
Immunogenicity, Safety Issues
Start: 2020-03-02
End: 2021-12-01
Updated: 2022-01-04
Related Papers
One-month evaluation of safety and immunogenicity of a Vi-DT typhoid conjugate vaccine (Bio-TCV®) in Indonesian subjects 6 months to 45 years: A phase III randomized clinical trial
Vaccine X
2025-05-20
1 citations